Skip to main content
Erschienen in: Medical Oncology 1/2011

01.12.2011 | Original Paper

COX-2 Gene increases tongue cancer cell proliferation and invasion through VEGF-C pathway

verfasst von: Yan-Hong Wang, Ming-Wei Wu, An-Kui Yang, Wei-Dong Zhang, Jian Sun, Tian-Run Liu, Yan-Feng Chen

Erschienen in: Medical Oncology | Sonderheft 1/2011

Einloggen, um Zugang zu erhalten

Abstract

COX-2 induces the proliferation and invasion of oral squamous cell carcinoma. In the present study, the role of the COX-2 gene in the tongue cancer cell proliferation and invasion was investigated. A short hairpin RNA (shRNA)method was used to knock down COX-2 gene expression and investigate the relationship between COX-2 and VEGF-C, and the role of the COX-2 gene for proliferation and invasion was also investigated in the tongue cancer cell Tca8113. COX-2 gene overexpressed in tongue cancer cell line. Suppressing the expression of COX-2 by shRNA could decrease cell proliferation comparing with control shRNA. Nevertheless, depressing COX-2 gene expression by shRNA reduced VEGF-C expression on both mRNA and protein levels. VEGF-C gene expression could be regulated by COX-2 gene. Our results suggested that COX-2 played essential roles in the proliferation and metastasis of tongue cancer, and COX-2 could serve as a potential chemotherapy target for tongue cancer.
Literatur
1.
Zurück zum Zitat Kruaysawat W, Aekplakorn W, Chapman RS. Survival time and prognostic factors of oral cancer in Ubon Ratchathani cancer center. J Med Assoc Thai. 2010;93(3):278–84.PubMed Kruaysawat W, Aekplakorn W, Chapman RS. Survival time and prognostic factors of oral cancer in Ubon Ratchathani cancer center. J Med Assoc Thai. 2010;93(3):278–84.PubMed
2.
Zurück zum Zitat Sun CZ, Chen FJ, Zeng ZY, Deng LF, Yang AK, Chen YF. Treatment and prognostic analysis of 92 cases with advanced mobile tongue squamous cell carcinoma. Zhonghua Kou Qiang Yi Xue Za Zhi. 2006;41(11):650–3.PubMed Sun CZ, Chen FJ, Zeng ZY, Deng LF, Yang AK, Chen YF. Treatment and prognostic analysis of 92 cases with advanced mobile tongue squamous cell carcinoma. Zhonghua Kou Qiang Yi Xue Za Zhi. 2006;41(11):650–3.PubMed
3.
Zurück zum Zitat Estilo CL, O-charoenrat P, Talbot S, Socci ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y, Boyle JO, Kraus DH, patel S, Shaha AR, Wong RJ, Huryn JM, Shah JP, Singh B. Oral tongue cancer gene expression profiling: identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer. 2009;12(9):11.CrossRef Estilo CL, O-charoenrat P, Talbot S, Socci ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y, Boyle JO, Kraus DH, patel S, Shaha AR, Wong RJ, Huryn JM, Shah JP, Singh B. Oral tongue cancer gene expression profiling: identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer. 2009;12(9):11.CrossRef
4.
Zurück zum Zitat Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002;94(4):252–66.PubMed Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002;94(4):252–66.PubMed
5.
Zurück zum Zitat Wang R, Wang X, Lin F, Gao P, Dong K, Zhang HZ. shRNA-targeted cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells. Mol Cell Biochem. 2008;317(1–2):179–88.PubMedCrossRef Wang R, Wang X, Lin F, Gao P, Dong K, Zhang HZ. shRNA-targeted cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells. Mol Cell Biochem. 2008;317(1–2):179–88.PubMedCrossRef
6.
Zurück zum Zitat Zhao X, Goswami M, Pokhriyal N, Ma H, Du H, Yao J, Victor TA, Polyak K, Sturgis CD, Band H, Band V. Cyclooxygenase-2 expression during immortalization and breast cancer progression. Cancer Res. 2008;68(2):467–75.PubMedCrossRef Zhao X, Goswami M, Pokhriyal N, Ma H, Du H, Yao J, Victor TA, Polyak K, Sturgis CD, Band H, Band V. Cyclooxygenase-2 expression during immortalization and breast cancer progression. Cancer Res. 2008;68(2):467–75.PubMedCrossRef
7.
Zurück zum Zitat Patel S, Chiplunkar S. Role of cyclooxygenase-2 in tumor progression and immune regulation in lung cancer. Indian J Biochem Biophys. 2007;44(6):419–28.PubMed Patel S, Chiplunkar S. Role of cyclooxygenase-2 in tumor progression and immune regulation in lung cancer. Indian J Biochem Biophys. 2007;44(6):419–28.PubMed
8.
Zurück zum Zitat Forones NM, Kawamura KY, Segreto HR, Artigiani Neto R, Focchi GR, Oshima CT. Expression of COX-2 in stomach carcinogenesis. J Gastrointest Cancer. 2008;39(1–4):4–10.PubMedCrossRef Forones NM, Kawamura KY, Segreto HR, Artigiani Neto R, Focchi GR, Oshima CT. Expression of COX-2 in stomach carcinogenesis. J Gastrointest Cancer. 2008;39(1–4):4–10.PubMedCrossRef
9.
Zurück zum Zitat Miyashita M, Makino H, Katsuta M, Nomura T, Shinji S, Kashiwabara M, Takahashi K, Kudo M, Ishiwata T, Naito Z, Tajiri T. Cyclo-oxygenase-2 over-expression is associated with human esophageal squamous cell carcinoma. J Nippon Med Sch. 2006;73(6):308–13.CrossRef Miyashita M, Makino H, Katsuta M, Nomura T, Shinji S, Kashiwabara M, Takahashi K, Kudo M, Ishiwata T, Naito Z, Tajiri T. Cyclo-oxygenase-2 over-expression is associated with human esophageal squamous cell carcinoma. J Nippon Med Sch. 2006;73(6):308–13.CrossRef
10.
Zurück zum Zitat Yamac D, Celenkoglu G, Coskun U, Akyurek N, Akcali Z, Dursun A, Koybasioglu F. Prognostic importance of COX-2 expression in patients with colorectal cancer. Pathol Res Pract. 2005;201(7):497–502.PubMedCrossRef Yamac D, Celenkoglu G, Coskun U, Akyurek N, Akcali Z, Dursun A, Koybasioglu F. Prognostic importance of COX-2 expression in patients with colorectal cancer. Pathol Res Pract. 2005;201(7):497–502.PubMedCrossRef
11.
Zurück zum Zitat Menczer J. Cox-2 expression in ovarian malignancies: a review of the clinical aspects. Eur J Obstet Gynecol Reprod Biol. 2009;146(2):129–312.PubMedCrossRef Menczer J. Cox-2 expression in ovarian malignancies: a review of the clinical aspects. Eur J Obstet Gynecol Reprod Biol. 2009;146(2):129–312.PubMedCrossRef
12.
Zurück zum Zitat Kern MA, Schirmacher P, Breinig M. Significance of cyclooxygenase-2 as a chemotherapeutic target in hepatocellular carcinoma. Verh Dtsch Ges Pathol. 2007;91:257–68.PubMed Kern MA, Schirmacher P, Breinig M. Significance of cyclooxygenase-2 as a chemotherapeutic target in hepatocellular carcinoma. Verh Dtsch Ges Pathol. 2007;91:257–68.PubMed
13.
Zurück zum Zitat Cao.Y, Prescott SM. Many action of cyclooxygenase-2 in cellular dynamics and cancer. J Cell Physiol. 2002;190(3):279–86.PubMedCrossRef Cao.Y, Prescott SM. Many action of cyclooxygenase-2 in cellular dynamics and cancer. J Cell Physiol. 2002;190(3):279–86.PubMedCrossRef
14.
Zurück zum Zitat Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994;107(4):1183–888.PubMed Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994;107(4):1183–888.PubMed
15.
Zurück zum Zitat Evans JF, Kargman SL. Cancer and cyclooxygenase-2 (COX-2) inhibition. Curr Pharm Des. 2004;10(6):627–34.PubMedCrossRef Evans JF, Kargman SL. Cancer and cyclooxygenase-2 (COX-2) inhibition. Curr Pharm Des. 2004;10(6):627–34.PubMedCrossRef
16.
Zurück zum Zitat Prescott SM. Is cyclooxygenase-2 the alpha and the omega in cancer? J Clin Invest. 2000;105(11):1511–3.PubMedCrossRef Prescott SM. Is cyclooxygenase-2 the alpha and the omega in cancer? J Clin Invest. 2000;105(11):1511–3.PubMedCrossRef
17.
Zurück zum Zitat Li WZ, Huo QJ, Wang XY, Xu F. (2010).Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression. Prostaglandins Other Lipid Mediat (Epub ahead of print). Li WZ, Huo QJ, Wang XY, Xu F. (2010).Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression. Prostaglandins Other Lipid Mediat (Epub ahead of print).
18.
Zurück zum Zitat Kwak YE, Jeon NK, Kim J, Lee EJ. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma. Ann N Y Acad Sci. 2007;1095:99–112.PubMedCrossRef Kwak YE, Jeon NK, Kim J, Lee EJ. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma. Ann N Y Acad Sci. 2007;1095:99–112.PubMedCrossRef
19.
Zurück zum Zitat Stöllberger C, Finsterer J. Side effects of conventional nonsteroidal anti-inflammatory drugs and celecoxib: more similarities than differences. South Med J. 2004;97(2):209.PubMedCrossRef Stöllberger C, Finsterer J. Side effects of conventional nonsteroidal anti-inflammatory drugs and celecoxib: more similarities than differences. South Med J. 2004;97(2):209.PubMedCrossRef
20.
Zurück zum Zitat Chang CH, Shau WY, Kuo CW, Chen ST, Lai. Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study. Stroke. 2010;41(9):1884–90.PubMedCrossRef Chang CH, Shau WY, Kuo CW, Chen ST, Lai. Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study. Stroke. 2010;41(9):1884–90.PubMedCrossRef
21.
Zurück zum Zitat Bhattacharjee RN, Timoshenko AV, Cai J, Lala PK. (2010) Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer. Cancer Sci (Epub ahead of print). Bhattacharjee RN, Timoshenko AV, Cai J, Lala PK. (2010) Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer. Cancer Sci (Epub ahead of print).
22.
Zurück zum Zitat Di JM, Zhou J, Zhou XL, Gao X, Shao CQ, Pang J, Sun QP, Zhang Y, Ruan XX. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer. Arch Med Res. 2009;40(4):268–75.PubMedCrossRef Di JM, Zhou J, Zhou XL, Gao X, Shao CQ, Pang J, Sun QP, Zhang Y, Ruan XX. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer. Arch Med Res. 2009;40(4):268–75.PubMedCrossRef
23.
Zurück zum Zitat Bruno T, Desantis A, Bossi G, Di Agostino S, Sorino C, De Nicola F, Iezzi S, Franchitto A, Benassi B, Galanti S, La Rosa F, Floridi A, Bellacosa A, Passananti C, Blandino G, Fanciulli M. Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activation. Cancer Cell. 2010;18(2):122–34.PubMedCrossRef Bruno T, Desantis A, Bossi G, Di Agostino S, Sorino C, De Nicola F, Iezzi S, Franchitto A, Benassi B, Galanti S, La Rosa F, Floridi A, Bellacosa A, Passananti C, Blandino G, Fanciulli M. Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activation. Cancer Cell. 2010;18(2):122–34.PubMedCrossRef
24.
Zurück zum Zitat Abbasi M, Lavasanifar A, Berthiaume LG, Weinfeld M, Uludağ H. (2010) Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells. Cancer (Epub ahead of print). Abbasi M, Lavasanifar A, Berthiaume LG, Weinfeld M, Uludağ H. (2010) Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells. Cancer (Epub ahead of print).
25.
Zurück zum Zitat Wang YH, Chen YF, Guo ZM, Zhang Q, Liu TR, Chen FJ. Reasons for recurrence and prognostic analysis of early stage squamous cell carcinoma of the oral tongue. Ai Zheng. 2009;28(5):524–7.PubMed Wang YH, Chen YF, Guo ZM, Zhang Q, Liu TR, Chen FJ. Reasons for recurrence and prognostic analysis of early stage squamous cell carcinoma of the oral tongue. Ai Zheng. 2009;28(5):524–7.PubMed
26.
Zurück zum Zitat Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005;438(7070):946–53.PubMedCrossRef Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005;438(7070):946–53.PubMedCrossRef
27.
Zurück zum Zitat Achen MG, Stacker SA. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. Int J Cancer. 2006;119(8):1755–60.PubMedCrossRef Achen MG, Stacker SA. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. Int J Cancer. 2006;119(8):1755–60.PubMedCrossRef
28.
Zurück zum Zitat Pepper MS, Tille JC, Nisato R, Skobe M. Lymphangiogenesis and tumor metastasis. Cell Tissue Res. 2003;314(1):167–77.PubMedCrossRef Pepper MS, Tille JC, Nisato R, Skobe M. Lymphangiogenesis and tumor metastasis. Cell Tissue Res. 2003;314(1):167–77.PubMedCrossRef
29.
Zurück zum Zitat Yonemura Y, Endo Y, Fujita H, Fushida S, Ninomiya I, Bandou E, Taniguchi K, Miwa K, Ohoyama S, Sugiyama K, Sasaki T. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res. 1999;5(7):1823–9.PubMed Yonemura Y, Endo Y, Fujita H, Fushida S, Ninomiya I, Bandou E, Taniguchi K, Miwa K, Ohoyama S, Sugiyama K, Sasaki T. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res. 1999;5(7):1823–9.PubMed
30.
Zurück zum Zitat Su JL, Shih JY, Yen ML, Jeng YM, Chang CC, Hsieh CY, Wei LH, Yang PC, Kuo ML. Cyclooxygenase-2 induces EP-1 and HER-2/Neu-dependent vascular endothelial growth factor-c up-regu-latin: a novel mechanism of lymphangiogensis in lung adenocarcinomn. Cancer Res. 2004;64(2):554–64.PubMedCrossRef Su JL, Shih JY, Yen ML, Jeng YM, Chang CC, Hsieh CY, Wei LH, Yang PC, Kuo ML. Cyclooxygenase-2 induces EP-1 and HER-2/Neu-dependent vascular endothelial growth factor-c up-regu-latin: a novel mechanism of lymphangiogensis in lung adenocarcinomn. Cancer Res. 2004;64(2):554–64.PubMedCrossRef
Metadaten
Titel
COX-2 Gene increases tongue cancer cell proliferation and invasion through VEGF-C pathway
verfasst von
Yan-Hong Wang
Ming-Wei Wu
An-Kui Yang
Wei-Dong Zhang
Jian Sun
Tian-Run Liu
Yan-Feng Chen
Publikationsdatum
01.12.2011
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe Sonderheft 1/2011
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9737-3

Weitere Artikel der Sonderheft 1/2011

Medical Oncology 1/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.